header

HIPGEN PARTNERSHIP

The Network consists of 9 partners from 7 Countries (Germany, Denmark, UK, Ireland, Italy, Switzerland and Israel).
The clinical and research centers in the Consortium have a renowned international expertise on hip fracture arthroplasty and cell therapy respectively while Pluristem is a lead company in the cell therapy development. All the Partners have been selected for their excellence in the field.
The HIPGEN consortium includes also the Irish CRO ICON that will manage the multicentre clinical trial, the company Be the Partner that has developed the platform for patient data management and the service provider company ALTA that will support the consortium in the coordination, dissemination and exploitation, allowing the scientists to focus on the science and the business developer on business. Finally, the International Osteoporosis foundation gives an added value of the consortium by filling the communication gap between science and patients.
The high degree of synergy among our participants ensures that the program will be successful and that their combined output will be greater than the sum of its parts. The European dimension of the project is an added value of the proposal, in terms of achieving the necessary critical mass (regarding patient enrollment, clinical infrastructures, availability of samples for analysis), financial support and good visibility.


consortium

HIPGEN PARTNERS

 

charite
bcrt

Participant No 1 (Coordinator) | CHARITE | Germany
pin Charité Universitaetsmedizin Berlin
pin Berlin-Brandenburg Center for Regenerative Therapies (BCRT)

 

uoxf
ndorms

Participant No 2 | UOXF | United Kingdom
pin The Chancellor, Masters and Scholars of the University of Oxford
pin Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORM)

 

ouh-dot

Participant No 3 | OUH-DOT | Denmark
pin Department of Orthopaedic Surgery and Traumatology, Odense University Hospital

 

crem

Participant No 4 | CREM | Italy
pin Centro di Ricerca E. Menni, Fondazione Poliambulanza - Istituto Ospedaliero

 

pluristem

Participant No 5 | Pluristem | Israel
pin Pluristem Therapeutics

 

btp

Participant No 6 | BTP | US
pin Be The Partner

 

icon

Participant No 7 | ICON | Ireland
pin ICON Clinical research

 

iof

Participant No 8 | IOF | Switzerland
pin International Osteoporosis Foundation

 

alta

Participant No 9 | ALTA | Italy
pin ALTA Ricerca e Sviluppo in Biotecnologie S.r.l.u.

 

HIPGEN CONTACTS

 

winkler

Project Coordinator
Dr. Tobias Winkler


stahler

Research Coordination, General administration
Frauke Stähler


zergiebel

Project Management, General administration
Anne Zergiebel


dessole

Grant Manager
Gabriella Dessole

 

For any further information on HIPGEN project, do not hesitate to contact us.
mail info@hipgen.eu